Trial Profile
A study evaluating effict of ideglira compared to non fixed administration of degludec and liraglutide in patients with type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2017
Price :
$35
*
At a glance
- Drugs Insulin degludec/liraglutide (Primary) ; Insulin degludec; Liraglutide
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 06 Oct 2017 New trial record
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes